Acrp30 Porcine, HEK exhibits metabolic and anti-inflammatory properties, as demonstrated in in vitro and in vivo studies:
Gluconeogenesis Inhibition: In primary hepatocytes, Acrp30 Porcine, HEK reduces glucose production with an ED50 of ~6 µg/ml .
Gene Modulation: Suppresses hepatic expression of PEPCK (phosphoenolpyruvate carboxykinase) and SREBP-1c (sterol regulatory element-binding protein 1c), key enzymes in gluconeogenesis and lipogenesis .
Improved Glucose Tolerance: In rodent models, sustained peripheral expression of Acrp30 enhances insulin sensitivity and reduces blood glucose levels .
Fatty Acid Oxidation: Promotes fatty acid uptake and oxidation in skeletal muscle, contributing to reduced triglyceride levels .
NF-κB Suppression: Inhibits endothelial NF-κB signaling via a cAMP-dependent pathway, reducing pro-inflammatory adhesion molecule expression .
Macrophage Polarization: Favors M2 macrophage differentiation, promoting tissue repair and clearance of apoptotic debris .
Acrp30 Porcine, HEK is widely used in metabolic disease research, including obesity, diabetes, and atherosclerosis.
In Vitro Gluconeogenesis: Acrp30 Porcine, HEK inhibits glucose production in hepatocytes at concentrations ≥6 µg/ml .
SDS-PAGE Purity: >90% purity confirmed via electrophoresis .
Species-Specific Effects: Porcine Acrp30 may exhibit partial functional overlap with human adiponectin but requires cross-species validation .
Complex Formation: Native adiponectin forms trimeric, hexameric, and high molecular weight (HMW) complexes; recombinant forms may require oligomerization for full activity .
Acrp30 Porcine (porcine adiponectin) is a 238-amino acid protein with a molecular mass of 26 kDa that belongs to the soluble defense collagen superfamily. When produced in HEK293 cells, it is typically fused to a 13-amino acid N-terminal FLAG tag for purification and detection purposes . Structurally, it has a collagen-like domain homologous with collagen VIII and X and a complement factor C1q-like globular domain .
The porcine variant shares approximately 80-85% sequence homology with human adiponectin (244 amino acids), though both contain characteristic collagen and globular domains essential for their function. These species-specific differences may affect epitope recognition and receptor binding, which researchers should consider when designing cross-reactivity experiments or using porcine models for translational research.
The HEK293 cell line is preferred for Acrp30 expression for several reasons:
Post-translational modifications: HEK293 cells provide mammalian-type glycosylation patterns important for adiponectin function
Proper protein folding: Unlike bacterial systems, HEK293 cells correctly form disulfide bonds essential for native conformation
Secretion efficiency: HEK293 cells efficiently secrete the protein into culture medium, facilitating purification
Biological activity: HEK-derived adiponectin demonstrates confirmed functionality in in vitro assays, such as inhibiting glucose production in hepatocytes with an ED50 of approximately 6 μg/ml
Oligomerization: The mammalian expression system enables formation of proper homotrimers, which are building blocks for higher-order complexes found in serum
Research has shown that HEK293 cells effectively produce biologically active Acrp30 that maintains its physiological properties, making this expression system valuable for generating research-grade protein.
Acrp30 has several distinctive structural features that are crucial to its function:
Domain organization: Contains a collagen-like domain and a C1q-like globular domain
Oligomerization: Forms homotrimers that serve as building blocks for higher-order complexes
Post-translational modifications: Undergoes glycosylation that affects oligomerization and function
Molecular weight: The monomeric form of porcine Acrp30 has a molecular mass of 26 kDa
Tag fusion: Recombinant versions often include N-terminal tags (like FLAG) that add approximately 1-2 kDa to the molecular weight
When analyzed by SDS-PAGE under reducing conditions, the protein appears as a single band at approximately 26-30 kDa, but under native conditions, it forms higher molecular weight complexes. The collagen domain facilitates triple helix formation in oligomeric structures, while the globular domain is responsible for receptor binding.
For optimal stability and functionality of Acrp30 Porcine, researchers should follow these guidelines:
Long-term storage: Store lyophilized protein at -20°C, where it remains stable for up to 24 months
Reconstitution: Add deionized water to the lyophilized pellet and allow it to dissolve completely
Aliquoting: After reconstitution, aliquot the protein to avoid repeated freeze-thaw cycles
Short-term storage: Reconstituted protein can be stored at 4°C for up to two weeks without significant change
Buffer composition: Typically formulated in buffers such as 20 mM Tris with 50 mM NaCl at pH 7.5
Proper handling is critical as adiponectin is sensitive to denaturation. Avoid vigorous shaking that may disrupt protein structure, and use low-protein binding tubes to prevent adsorption to container surfaces when working with dilute solutions.
Acrp30 Porcine expressed in HEK cells can be used in various research applications:
ELISA development: For quantitative measurement of adiponectin levels, using systems like the DuoSet ELISA
Western blotting: For detection and analysis of adiponectin expression and post-translational modifications
Cell culture studies: To investigate adiponectin signaling pathways, particularly in relation to insulin sensitivity
Gluconeogenesis assays: To study inhibitory effects on glucose production in hepatocytes, with demonstrated ED50 of ~6 μg/ml
Gene therapy models: As evidenced by studies using adeno-associated virus vectors encoding adiponectin to treat obesity and insulin resistance
Metabolic pathway analysis: To examine effects on PEPCK and SREBP-1c expression in the liver, key genes in gluconeogenesis and lipogenesis
Recombinant Acrp30 has been successfully used in studies demonstrating significant reductions in body weight, food intake, and improved peripheral insulin sensitivity in animal models .
Acrp30 regulates hepatic glucose metabolism through several molecular mechanisms:
PEPCK suppression: Acrp30 significantly reduces phosphoenolpyruvate carboxykinase (PEPCK) expression in the liver, which is the rate-limiting enzyme in gluconeogenesis
AMPK activation: Adiponectin activates AMP-activated protein kinase (AMPK), leading to phosphorylation and inactivation of acetyl-CoA carboxylase
Lipogenesis regulation: Acrp30 modulates SREBP-1c (sterol regulatory element-binding protein 1c) expression, affecting hepatic lipid metabolism
Insulin sensitization: Enhances insulin signaling pathways in hepatocytes
Research has demonstrated that in Sprague-Dawley rats, high-fat diet significantly increases PEPCK levels, while Acrp30 expression reduces PEPCK expression even below levels observed in normal diet control animals . This powerful suppression of gluconeogenesis contributes to the protein's ability to improve glucose homeostasis and insulin sensitivity.
The expression system significantly impacts Acrp30 functionality through several mechanisms:
Expression System | Post-translational Modifications | Oligomerization | Biological Activity | Advantages/Limitations |
---|---|---|---|---|
HEK293 cells | Mammalian-type glycosylation, proper hydroxylation | Forms appropriate trimers and higher-order structures | High (ED50 ~6 μg/ml in gluconeogenesis inhibition) | Gold standard for functional studies, higher cost |
E. coli | Lacks glycosylation and hydroxylation | Limited oligomerization, primarily monomeric | Reduced, primarily through globular domain | Economical, high yield, but limited functionality |
Yeast | Altered glycosylation pattern | Partial oligomerization | Intermediate | Good yield, economical, incomplete post-translational modifications |
CHO cells | Similar to HEK293, slight differences in glycosylation | Forms proper oligomers | High, comparable to HEK | Suitable for larger-scale production |
HEK293-derived Acrp30 demonstrates superior functionality in research applications due to proper post-translational modifications that preserve the native structure and oligomerization capacity . Studies have shown that HEK293 cells secreting Acrp30 exhibit improved protein production characteristics , making this system particularly valuable for generating functionally relevant adiponectin for research purposes.
The oligomerization state of recombinant Acrp30 is influenced by several factors:
Post-translational modifications: Glycosylation and hydroxylation of lysine residues in the collagen domain are critical for higher-order structure formation
Buffer conditions: pH, ionic strength, and presence of divalent cations affect assembly of oligomers
Protein concentration: Higher concentrations favor formation of larger oligomeric complexes
Reducing agents: Presence of reducing agents disrupts disulfide bonds essential for maintaining multimeric structures
Temperature: Both storage and experimental temperatures influence oligomer stability
Tags: N-terminal tags may slightly modify the oligomerization properties
The distribution of oligomeric forms (trimers, hexamers, and high-molecular-weight multimers) is functionally significant as research indicates that high-molecular-weight forms correlate more strongly with insulin sensitivity. Therefore, characterizing the oligomeric profile is crucial for interpreting functional outcomes in experimental systems using recombinant Acrp30.
For reliable assessment of Acrp30 activity in metabolic assays, particularly gluconeogenesis inhibition:
Cell model selection:
Primary hepatocytes preferred over hepatoma cell lines
Freshly isolated cells maintain higher sensitivity to adiponectin
Experimental conditions:
Controls:
Positive control: Insulin (10-100 nM)
Negative control: Inactive protein or buffer
Vehicle control: Buffer used for protein reconstitution
Readout methods:
Research has demonstrated that adiponectin significantly reduces PEPCK expression levels in liver, a key enzyme in the gluconeogenesis pathway, confirming its metabolic effects .
When working with FLAG-tagged Acrp30, researchers should consider several technical aspects:
Detection considerations:
FLAG tag enables consistent detection using standardized anti-FLAG antibodies
May alter antibody recognition of native epitopes in adiponectin-specific assays
Functional implications:
Experimental design:
For critical functional studies, confirm key findings with untagged protein when possible
In immunoprecipitation experiments, consider potential steric hindrance from the tag
For crystallography studies, the flexible tag may impede crystal formation
Quantitative analysis:
Standard curves must use the same form (tagged or untagged) as experimental samples
The tag adds approximately 1 kDa to the molecular weight, affecting migration in gels
The Acrp30 Porcine recombinant typically contains the 238-amino acid native protein fused to a 13-amino acid N-terminal FLAG tag, resulting in specific detection properties that researchers should account for in experimental design .
The correlation between in vivo and in vitro effects of Acrp30 shows both similarities and important differences:
Metabolic effects:
Dose-response relationships:
In vitro: Linear dose-response curves typically observed
In vivo: Complex relationships due to tissue distribution, receptor regulation, and compensatory mechanisms
Temporal dynamics:
Long-term adaptations:
Mechanistic insights:
Long-term studies using recombinant adeno-associated virus vectors encoding Acrp30 have demonstrated sustained (up to 280 days) significant reduction in body weight and improved insulin sensitivity, validating the physiological relevance of in vitro findings .
Adiponectin is a hormone secreted by adipocytes (fat cells) that plays a crucial role in regulating glucose levels and fatty acid breakdown. It exists in various multimeric forms, with the high molecular weight (HMW) form being the most biologically active. Adiponectin has significant implications in metabolic processes, including insulin sensitivity and anti-inflammatory responses .
Recombinant adiponectin is produced using various expression systems, including Escherichia coli, mammalian cells, and insect cells. Among these, the human embryonic kidney (HEK) 293 cell line is a popular choice due to its ability to produce properly folded and post-translationally modified proteins .
Recombinant adiponectin, particularly the HMW form, has shown promise in various therapeutic applications. It has been studied for its potential to treat metabolic disorders, such as diabetes and obesity, due to its insulin-sensitizing and anti-inflammatory properties . Additionally, recombinant adiponectin can be used in research to better understand its role in metabolic and cardiovascular diseases .